| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/28/2010 | US20100022493 Use of mometasone furoate for treating airway passage and lung disease |
| 01/28/2010 | US20100022472 Liquid, eye-instillable preparations comprising sodium hyaluronate |
| 01/28/2010 | US20100022437 Liquid Support |
| 01/28/2010 | US20100021554 Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
| 01/28/2010 | US20100021553 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 01/28/2010 | US20100021552 Polysaccharide nanofibers having antimicrobial properties |
| 01/28/2010 | US20100021551 Process for preparing nanoparticles of chitosan in water phase |
| 01/28/2010 | US20100021550 Radiopaque biodegradable vascular embolic microspheres |
| 01/28/2010 | US20100021549 Microparticle oral form useful for the modified release of nanoparticles |
| 01/28/2010 | US20100021548 Use of microparticles with adsorbed antigen to stimulate immune responses |
| 01/28/2010 | US20100021547 Pharmaceutical composition for piperidinoalkanol compounds |
| 01/28/2010 | US20100021546 Controlled-release immunogenic formulations to modulate immune response |
| 01/28/2010 | US20100021545 Injectable in situ self-forming mineral-polymer hybrid composition and uses thereof |
| 01/28/2010 | US20100021544 Hydrogel and biomedical applications thereof |
| 01/28/2010 | US20100021543 Peroral solid pain killer preparation |
| 01/28/2010 | US20100021542 Extended release oral dosage composition |
| 01/28/2010 | US20100021541 Microparticulate form of a Tetrahydropyridine derivative |
| 01/28/2010 | US20100021540 Tablets and Preparation Thereof |
| 01/28/2010 | US20100021539 Modified Release 1-[(3-Hydroxy-Adamant-1-Ylamino)-Acetyl]-Pyrrolidine-2(S)-Carbonitrile Formulation |
| 01/28/2010 | US20100021538 Pharmaceutical compositions containing heparin derivatives |
| 01/28/2010 | US20100021537 Comprising at least one digestive enzyme (e.g., pancrelipase); useful for treating or preventing disorders associated with digestive enzyme deficiencies; enteric coated enzyme compositions and dosage forms that exhibit minimal loss of activity under typical storage conditions |
| 01/28/2010 | US20100021536 Enhanced-diffusion capsule |
| 01/28/2010 | US20100021535 Light-stabilized soft capsule formulations |
| 01/28/2010 | US20100021534 Injection-molded water soluble container |
| 01/28/2010 | US20100021533 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| 01/28/2010 | US20100021532 Personal care composition containing yeast/polyphenol ferment extract |
| 01/28/2010 | US20100021531 Method for production of liposome preparation |
| 01/28/2010 | US20100021530 Enhanced trans-keratin drug delivery |
| 01/28/2010 | US20100021529 Step-down estrogen regimen for women receiving estrogen therapy |
| 01/28/2010 | US20100021528 Conformable structured therapeutic dressing |
| 01/28/2010 | US20100021527 Collagen-related peptides and uses thereof and hemostatic foam substrates |
| 01/28/2010 | US20100021526 Ph modulated films for delivery of actives |
| 01/28/2010 | US20100021525 Method for Producing Sterol Formulations |
| 01/28/2010 | US20100021524 Pimethixene derivatives for promoting bone growth |
| 01/28/2010 | US20100021520 Biomaterial implants |
| 01/28/2010 | US20100021519 Compositions and Methods for Treating or Preventing Diseases of Body Passageways |
| 01/28/2010 | US20100021518 Foam carrier for bone grafting |
| 01/28/2010 | US20100021517 Non-woven fiber fabric |
| 01/28/2010 | US20100021516 Drug depots having one or more anchoring members |
| 01/28/2010 | US20100021514 Infection-resistant polyurethane foams, method for producing the same and use thereof in antiseptic wound dressings |
| 01/28/2010 | US20100021510 Neuronal exocytosis inhibiting peptides |
| 01/28/2010 | US20100021507 Method and Composition for Making an Orally Disintegrating Dosage Form |
| 01/28/2010 | US20100021506 Nitric oxide gel apparatus and method |
| 01/28/2010 | US20100021505 Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients |
| 01/28/2010 | US20100021439 Methods and compositions for treating intervertebral disc degeneration |
| 01/28/2010 | US20100021419 Stable Pharmaceutical Composition Comprising Granulocyte-Colony Stimulating Factor |
| 01/28/2010 | US20100021395 Crystalline forms of a biphenyl compound |
| 01/28/2010 | US20100021394 High penetration prodrug compositions of 1h-imidazo[4,5-c]quinolin-4-amines and 1h-imidazo[4,5-c]quinolin-4-amine-related compounds |
| 01/28/2010 | US20100021393 Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate |
| 01/28/2010 | US20100021380 Dieghylenetriaminepentaacetic acid (dtpa)-modified ferrofluid, preparation method of the same and uses of the same in preparation of peptide ferrofluid |
| 01/28/2010 | US20100018523 Composition, device, and method for treating sexual dysfunction via inhalation |
| 01/28/2010 | DE10297018B4 Depotmikrokügelchen für die Injektion von Huperzin-A-Verbindungen Depot microspheres for injection of Huperzine A compounds |
| 01/28/2010 | DE102008034944A1 Mikroemulsion Microemulsion |
| 01/28/2010 | CA2767560A1 Atovaquone with a particle size diameter range (d90) of greater than 3um to about 10um |
| 01/28/2010 | CA2737144A1 Methods for treating viral disorders |
| 01/28/2010 | CA2731938A1 Solid pharmaceutical composition comprising exemestane |
| 01/28/2010 | CA2731769A1 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | CA2731766A1 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 01/28/2010 | CA2731455A1 Methods of administering topical antifungal formulations for the treatment of fungal infections |
| 01/28/2010 | CA2731445A1 Topical anti-inflammatory combination |
| 01/28/2010 | CA2731312A1 Pharmaceutical formulation for treating the upper digestive tract |
| 01/28/2010 | CA2731271A1 Stable aqueous solution composition containing sulfonamide compound |
| 01/28/2010 | CA2730005A1 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| 01/28/2010 | CA2728357A1 Device and method for controlling insects |
| 01/27/2010 | EP2147686A1 Method for packaging contact lenses |
| 01/27/2010 | EP2147676A1 Allergen inactivator |
| 01/27/2010 | EP2147671A1 The composition comprising l-carnitine or derivatives thereof and its use |
| 01/27/2010 | EP2147670A1 Chemically stable compositions of 4-hydroxy tamoxifen |
| 01/27/2010 | EP2147669A2 Rapidly dissolving robust dosage form |
| 01/27/2010 | EP2146747A1 Novel strategies for delivery of active agents using micelles and particles |
| 01/27/2010 | EP2146738A2 Wound healing compositions containing keratin biomaterials |
| 01/27/2010 | EP2146727A1 High viscosity macromolecular compositions for treating ocular conditions |
| 01/27/2010 | EP2146700A1 Protein-modified nano-droplets, compositions and methods of production |
| 01/27/2010 | EP2146699A2 Pharmaceutical compositions comprising oxcarbazepine |
| 01/27/2010 | EP2146698A2 Rapidly dispersible vaginal tablet that provides a bioadhesive gel |
| 01/27/2010 | EP2146697A1 Pharmaceutical compositions |
| 01/27/2010 | EP2146696A2 Granular material for dosage forms |
| 01/27/2010 | EP2146695A2 Pharmaceutical compositions |
| 01/27/2010 | EP2146694A1 Formulation of active agent loaded activated plga nanoparticles for targeted cancer nano-therapeutics |
| 01/27/2010 | EP2146693A2 Solifenacin compositions |
| 01/27/2010 | EP2146692A1 Proliposomal and liposomal compositions |
| 01/27/2010 | EP2146691A2 Nucleic acid microparticles for pulmonary delivery |
| 01/27/2010 | EP2146690A2 Oral cephalotaxine dosage forms |
| 01/27/2010 | EP2146689A2 Solvent-cast microneedle arrays containing active |
| 01/27/2010 | EP2146588A1 Method for the production of a food, a food supplement, or consumable good |
| 01/27/2010 | EP1594466B1 Virosome-like-particles |
| 01/27/2010 | EP1489125B1 Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicines |
| 01/27/2010 | EP1448604B1 Preparation method of solvent-free water-dispersible hydroxypropyl methyl cellulose phthalate nanoparticle |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/27/2010 | CN201389195Y Plaster substrate adopting PU membrane bottom lining layer |
| 01/27/2010 | CN101636153A Time-specific delayed/pulsatile release dosage forms |
| 01/27/2010 | CN101636152A Controlled-release preparation containing cilostazol and process for the preparation thereof |
| 01/27/2010 | CN101636151A Stabilized micronised particles |
| 01/27/2010 | CN101636150A Method for producing pulverized organic compound particle |
| 01/27/2010 | CN101636149A Powders for reconstitution |
| 01/27/2010 | CN101636148A Linker-based lecithin microemulsion delivery vehicles |
| 01/27/2010 | CN101636147A Intranasal, buccal, and sublingual administration of metanicotine analogs |
| 01/27/2010 | CN101636146A Ophthalmic pharmaceutical compositions and uses thereof |
| 01/27/2010 | CN101636145A Long term 24 hour intestinal administration of levodopa/carbidopa |
| 01/27/2010 | CN101636144A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |